SIGA Technologies (NASDAQ:SIGA) Trading Down 5.9%

SIGA Technologies, Inc. (NASDAQ:SIGA)’s share price traded down 5.9% on Tuesday . The company traded as low as $7.86 and last traded at $7.86. 228,849 shares traded hands during mid-day trading, a decline of 62% from the average session volume of 605,176 shares. The stock had previously closed at $8.35.

SIGA Technologies Price Performance

The stock has a 50 day simple moving average of $5.69 and a two-hundred day simple moving average of $5.42. The company has a market capitalization of $608.55 million, a price-to-earnings ratio of 9.01 and a beta of 0.85.

SIGA Technologies Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, April 11th. Investors of record on Tuesday, March 26th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, March 25th. This is a positive change from SIGA Technologies’s previous dividend of $0.45.

Institutional Investors Weigh In On SIGA Technologies

A number of institutional investors have recently added to or reduced their stakes in the business. Point72 Middle East FZE acquired a new position in SIGA Technologies in the 4th quarter valued at $27,000. Tower Research Capital LLC TRC raised its stake in SIGA Technologies by 200.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,955 shares of the company’s stock worth $45,000 after acquiring an additional 5,309 shares during the period. China Universal Asset Management Co. Ltd. raised its stake in SIGA Technologies by 351.7% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 8,225 shares of the company’s stock worth $46,000 after acquiring an additional 6,404 shares during the period. UBS Group AG increased its stake in shares of SIGA Technologies by 30.3% in the second quarter. UBS Group AG now owns 4,596 shares of the company’s stock valued at $53,000 after purchasing an additional 1,070 shares during the period. Finally, Evergreen Capital Management LLC bought a new position in shares of SIGA Technologies in the third quarter valued at approximately $57,000. Hedge funds and other institutional investors own 55.40% of the company’s stock.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.